Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Blood Flow01:29

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of neurone specific enolase to prognosticate neurological recovery and long term neurological outcomes in OOHCA patients.

Journal of the Intensive Care Society·2023
Same author

Believe Nothing, Question Everything-Use Your Data Sense-Check in Assessing Medical Research.

Critical care medicine·2022
Same author

When Will You Meet the Medical Emergency Team? Just Ask.

Critical care medicine·2022
Same author

Mortality and readmission rates of patients discharged in-hours and out-of-hours from a British ICU over a 3-year period.

Scientific reports·2022
Same author

Ticking the "Family Meeting" Box-Unlikely to Be Enough.

Critical care medicine·2020
Same author

How to Recover From Critical Illness-Is It All in the Brochure?

Critical care medicine·2019

Related Experiment Video

Updated: May 27, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Haemodynamic optimisation: are we dynamic enough?

Sophie J Parker1, Owen Boyd

  • 1Royal Sussex County Hospital, Eastern Road, Brighton, East Sussex, BN2 0JH, UK.

Critical Care (London, England)
|November 15, 2011
PubMed
Summary

Optimizing hemodynamics in high-risk surgery improves outcomes. Despite evidence supporting cardiac output monitoring, fluid resuscitation, and inotropes, these practices are not universally applied, hindering standardized care.

Area of Science:

  • Anesthesiology
  • Critical Care Medicine
  • Surgical Outcomes

Background:

  • Perioperative hemodynamic optimization is proven to enhance patient outcomes and reduce complications in high-risk surgical patients.
  • Established evidence supports cardiac output monitoring, fluid resuscitation, and inotropic agents as the standard of care for complex surgical cases.

Purpose of the Study:

  • To explore the reasons behind the inconsistent clinical application of evidence-based hemodynamic optimization principles.
  • To identify barriers to the universal adoption of advanced hemodynamic monitoring and management strategies in high-risk surgical patients.

Main Methods:

  • Review of existing literature on perioperative hemodynamic optimization.
  • Analysis of factors influencing clinical practice variations in managing high-risk surgical patients.

More Related Videos

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion
12:15

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion

Published on: February 17, 2013

Related Experiment Videos

Last Updated: May 27, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion
12:15

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion

Published on: February 17, 2013

Main Results:

  • Clinicians do not universally implement recommended hemodynamic optimization techniques despite strong evidence.
  • There are significant barriers to the widespread application of cardiac output monitoring, fluid resuscitation, and inotropes in routine practice.

Conclusions:

  • Understanding the reasons for non-adherence is crucial for improving the standardization of care.
  • Addressing these barriers can facilitate the consistent application of evidence-based practices for better surgical outcomes.